Clinical Trial

Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients with idiopathic scoliosis who undergo the same procedure. This will be accomplished using serum biomarkers of immune response. Anecdotally, it appears that patients with neuromuscular scoliosis have more fluid resuscitation needs compared to patients with idiopathic scoliosis. The proposed hypothesis of this observation is that patients with neuromuscular scoliosis have a more profound immune response compared to patients with idiopathic scoliosis, which leads to a more robust systematic inflammatory response syndrome.
Protocol Amendment History 1 change
critical Phase changed: not applicable -> not specified 2026-08-07
Trial Details
NCT Number NCT07734467
Lead Sponsor Ambrish Patel
Conditions Posterior Spinal Fusion, Idiopathic Scoliosis, Neuromuscular Scoliosis
Enrollment 20 participants
Start Date 2026-10
Primary Completion 2029-06 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06